Metrics to compare | 225220 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship225220PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.7x | 5.9x | −0.3x | |
PEG Ratio | −0.10 | 0.05 | 0.00 | |
Price/Book | 0.4x | 1.3x | 2.6x | |
Price / LTM Sales | 2.7x | 1.8x | 2.9x | |
Upside (Analyst Target) | - | 82.8% | 67.3% | |
Fair Value Upside | Unlock | 23.6% | 10.3% | Unlock |
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products. Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.